Results 11 to 20 of about 24,159 (191)

Restenosis of Coronary Arteries in Patients with Coronavirus Infection: Case Series

Case Reports in Medicine, 2023
Introduction. Coronavirus infection is a risk factor for vascular thrombosis. This is of particular importance for patients undergoing myocardial revascularization since this infection can be a trigger for the formation of restenosis in the area of a ...
Gulnara Batenova, Lyudmila Pivina, Evgeny Dedov, Altay Dyussupov, Zhanar Zhumanbayeva, Yerbol Smail, Tatyana Belikhina, Laura Pak, Diana Ygiyeva   +8 more
doaj   +1 more source

Prevention of coronary restenosis by stenting [PDF]

European Heart Journal, 1988
Balloon angioplasty fails to provide acceptable long-term results for a significant proportion of patients. An intravascular mechanical support, developed with the aim of preventing restenosis and acute closure of diseased arteries after transluminal angioplasty, was implanted in 44 patients (39 male and five female), aged from 35 to 70 years (mean 56 ...
Sigwart, U., Kaufmann, U., Goy, J. J., Grbic, M., Golf, S., Essinger, A., Fischer, A., Sadeghi, H., Mirkovitch, V., Kappenberger, L.   +9 more
openaire   +4 more sources

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)

Pakistan Armed Forces Medical Journal, 2020
Objective: To study the frequency of In-Stent Restenosis and its treatment in patients undergoing Percutaneous Coronary Intervention for coronary artery disease. Study Design: Descriptive cross sectional study.
Waseem Raja, Naseer Ahmed Samore, Mohsin Saif, Javeria Kamran, Sidra Waheed, Naeem Tariq, Farhan Tuyyab, Abdul Hameed Siddiqui   +7 more
doaj   +1 more source

A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients

Frontiers in Cardiovascular Medicine, 2022
PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng, Ying Zhao, Haiyan Wang, Jiayu Zhao, Xun Wang, Jianping Shi   +5 more
doaj   +1 more source

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents

Российский кардиологический журнал, 2019
Aim. To identify the effect of preprocedural laboratory parameters on the occurrence of in-stent restenosis in various types of stents, to assess the significance of gender, age and various forms of coronary artery disease (CAD) as risk factors for ...
D. V. Shames, A. S. Galyavich, Z. M. Galeeva, L. V. Baleeva   +3 more
doaj   +1 more source

DETECTING PAINLESS MYOCARDIAL ISCHEMIA IN A PATIENT WITH RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION

Атеротромбоз, 2016
Restenosis is a complication of percutaneous coronary interventions which results in the destabilization of coronary heart disease. Presents a clinical case of detection of restenosis using stress Echocardiography one year after percutaneous coronary ...
M. A. Elkanova, V. N. Shitov, U. V. Botvina, V. V. Lopukhova, M. A. Saidova, Y. A. Karpov   +5 more
doaj   +1 more source

Clinical condition and cardiovascular risk factors displaying neoatherosclerosis in stented coronary arteries with developing restenosis

Кардиоваскулярная терапия и профилактика, 2016
Aim. To study the significance of clinical parameters and cardiovascular risk factors (CVR) for restenosis development at long terms after percutaneous coronary intervention (PCI) as a possible displaying of neoatherosclerosis development (NA).Material ...
V. P. Mazaev, A. A. Komkov, S. V. Ryazanova   +2 more
doaj   +1 more source

Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis

BMC Medicine, 2012
Background The benefit of the coronary collateral circulation (natural bypass network) on survival is well established. However, data derived from smaller studies indicates that coronary collaterals may increase the risk for restenosis after percutaneous
Meier Pascal, Indermuehle Andreas, Pitt Bertram, Traupe Tobias, de Marchi Stefano F, Crake Tom, Knapp Guido, Lansky Alexandra J, Seiler Christian   +8 more
doaj   +1 more source

Restenosis after coronary angioplasty

Disease-a-Month, 1993
Coronary angioplasty is used to treat coronary disease in many patients. Indications for angioplasty have expanded since it was first performed, mainly as a result of improvement in equipment and techniques. One problem with coronary angioplasty is the phenomenon of renarrowing of the treated coronary lesion, a process called restenosis.
H V, Anderson, S J, Vignale, C R, Benedict, J T, Willerson   +3 more
openaire   +4 more sources

Restenosis following coronary angioplasty

Clinical Cardiology, 1991
AbstractRestenosis is the most important problem limiting the success of coronary angioplasty. Clinically, restenosis is seen in approximately one‐third of patients undergoing percutaneous transluminal coronary angioplasty. Several clinical and angiographic risk factors have been identified which may contribute to the development of restenosis ...
S P, Karas, E C, Santoian, M B, Gravanis
openaire   +2 more sources